Brief: TG Therapeutics Secures An Additional $500 Million In Non-Dilutive Capital From Blue Owl And Expands Share Repurchase Program To $300 Million

TG Therapeutics

19/03/2026 11:55

March 19 (Reuters) - TG Therapeutics Inc TGTX.O:

TG THERAPEUTICS SECURES AN ADDITIONAL $500 MILLION IN NON-DILUTIVE CAPITAL FROM BLUE OWL AND EXPANDS SHARE REPURCHASE PROGRAM TO $300 MILLION

TG THERAPEUTICS INC - ENTERS FIVE-YEAR $750 MILLION CREDIT FACILITY WITH BLUE OWL CAPITAL

TG THERAPEUTICS INC - INCREASES SHARE REPURCHASE PROGRAM TO $300 MILLION

Source text: ID:nGNX9Ptsjn

Further company coverage: TGTX.O

 ((((Reuters.Briefs@thomsonreuters.com;));))